BackInhibikase Therapeutics Overview
Inhibikase Therapeutics Inc

Inhibikase Therapeutics Target Price

Analysts' 12-month price predictions for IKT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.67

Average Target Price

$5.00199.4% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-10Oppenheimer$5199.4% upsideOpen
2025-12-11Cantor FitzgeraldOlivia Brayer$4139.5% upsideOpen
2024-11-08JefferiesDennis Ding$8379% upsideOpen
2024-10-11H.C. WainwrightEdward White$5199.4% upsideOpen